Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Spago Nanomedical AB (publ) has received approval from the Swedish Medical Products Agency to initiate the first clinical trial with the contrast agent SpagoPix (SN132D) in patients with breast cancer.
The new BradyJet J2000 easily prints reliable, full colour labels for every sample!
We are happy to be able to announce that ReproUnion has been granted funding for the continuance of the ReproUnion project, which will help establish and further develop the Medicon Valley region as a world-class life science cluster within infertility treatment.
Spago Nanomedical will participate in Avanza Börsdag, a collaboration between Avanza and Financial Hearings, on Wednesday November 28, 2018.
Mabtech, a worldwide supplier of kits and reagents for immune monitoring, today unveil a new revolutionary FluoroSpot & ELISpot reader called Mabtech IRIS™ with their R&D partner Qamcom Research and Technology Stockholm, a Technology Application Expert. Mabtech IRIS is a spot reader with precision and accuracy previously not available in the market, creating exciting new possibilities for the research community.